Spark Therapeutics: Inside The Dramatic FDA AdCom Meeting By: Benzinga via Benzinga October 13, 2017 at 08:25 AM EDT Analysts at Cantor Fitzgerald continue to hold a bullish stance on Spark Therapeutics Inc (NASDAQ: ONCE) after the U.S. Food and Drug ... Read More >> Related Stocks: Spark Therap